Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385514133> ?p ?o ?g. }
- W4385514133 endingPage "667" @default.
- W4385514133 startingPage "655" @default.
- W4385514133 abstract "Over three years have passed since the emergence of coronavirus disease 2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome, remains long overdue. Currently, there is no standardized treatment available for long-COVID, primarily due to the lack of funding for post-acute infection syndromes (PAIS). Nevertheless, the past few years have seen a renewed interest in long-COVID research, with billions of dollars allocated for this purpose. As a result, multiple randomized controlled trials (RCTs) have been funded in the quest to find an effective treatment for long-COVID.This systematic review identified and evaluated the potential of current drug treatments for long-COVID, examining both completed and ongoing RCTs.We identified four completed and 22 ongoing RCTs, investigating 22 unique drugs. However, most drugs were deemed to not have high potential for treating long-COVID, according to three pre-specified domains, a testament to the ordeal of treating long-COVID. Given that long-COVID is highly multifaceted with several proposed subtypes, treatments likely need to be tailored accordingly. Currently, rintatolimod appears to have modest to high potential for treating the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) subtype, LTY-100 and Treamid for pulmonary fibrosis subtype, and metformin for general long-COVID prevention." @default.
- W4385514133 created "2023-08-04" @default.
- W4385514133 creator A5002825649 @default.
- W4385514133 creator A5013392812 @default.
- W4385514133 creator A5015125630 @default.
- W4385514133 creator A5016364986 @default.
- W4385514133 creator A5022201674 @default.
- W4385514133 creator A5022672267 @default.
- W4385514133 creator A5024561569 @default.
- W4385514133 creator A5026310855 @default.
- W4385514133 creator A5026812327 @default.
- W4385514133 creator A5029851532 @default.
- W4385514133 creator A5031830797 @default.
- W4385514133 creator A5042664334 @default.
- W4385514133 creator A5044299075 @default.
- W4385514133 creator A5047427323 @default.
- W4385514133 creator A5057848689 @default.
- W4385514133 creator A5060037815 @default.
- W4385514133 creator A5062380682 @default.
- W4385514133 creator A5074929889 @default.
- W4385514133 creator A5076507643 @default.
- W4385514133 creator A5077693787 @default.
- W4385514133 creator A5080904572 @default.
- W4385514133 creator A5082100593 @default.
- W4385514133 creator A5092587834 @default.
- W4385514133 creator A5092587835 @default.
- W4385514133 creator A5092587836 @default.
- W4385514133 date "2023-07-03" @default.
- W4385514133 modified "2023-10-16" @default.
- W4385514133 title "Experimental drugs in randomized controlled trials for long-COVID: what’s in the pipeline? A systematic and critical review" @default.
- W4385514133 cites W1966756094 @default.
- W4385514133 cites W1982922017 @default.
- W4385514133 cites W1993145638 @default.
- W4385514133 cites W1998038574 @default.
- W4385514133 cites W2008087869 @default.
- W4385514133 cites W2014784482 @default.
- W4385514133 cites W2016920052 @default.
- W4385514133 cites W2022292163 @default.
- W4385514133 cites W2033240561 @default.
- W4385514133 cites W2034031225 @default.
- W4385514133 cites W2045674421 @default.
- W4385514133 cites W2052808839 @default.
- W4385514133 cites W2055830213 @default.
- W4385514133 cites W2066196246 @default.
- W4385514133 cites W2100497492 @default.
- W4385514133 cites W2112888652 @default.
- W4385514133 cites W2134497001 @default.
- W4385514133 cites W2142563310 @default.
- W4385514133 cites W2149699306 @default.
- W4385514133 cites W2156098321 @default.
- W4385514133 cites W2171159512 @default.
- W4385514133 cites W2321182980 @default.
- W4385514133 cites W2341344535 @default.
- W4385514133 cites W2415233021 @default.
- W4385514133 cites W2771770459 @default.
- W4385514133 cites W2807702373 @default.
- W4385514133 cites W2809969852 @default.
- W4385514133 cites W2891593039 @default.
- W4385514133 cites W2909275830 @default.
- W4385514133 cites W2970684805 @default.
- W4385514133 cites W2991792334 @default.
- W4385514133 cites W3004296706 @default.
- W4385514133 cites W3006118591 @default.
- W4385514133 cites W3013207865 @default.
- W4385514133 cites W3023915741 @default.
- W4385514133 cites W3023999991 @default.
- W4385514133 cites W3040988373 @default.
- W4385514133 cites W3087262009 @default.
- W4385514133 cites W3092136311 @default.
- W4385514133 cites W3092230929 @default.
- W4385514133 cites W3094687032 @default.
- W4385514133 cites W3104119473 @default.
- W4385514133 cites W3109840215 @default.
- W4385514133 cites W3110875071 @default.
- W4385514133 cites W3111400428 @default.
- W4385514133 cites W3119203274 @default.
- W4385514133 cites W3123099249 @default.
- W4385514133 cites W3127556689 @default.
- W4385514133 cites W3128996935 @default.
- W4385514133 cites W3129062455 @default.
- W4385514133 cites W3130452246 @default.
- W4385514133 cites W3134564766 @default.
- W4385514133 cites W3152668228 @default.
- W4385514133 cites W3153467516 @default.
- W4385514133 cites W3165449608 @default.
- W4385514133 cites W3169473462 @default.
- W4385514133 cites W3193073519 @default.
- W4385514133 cites W3194420263 @default.
- W4385514133 cites W3196693206 @default.
- W4385514133 cites W3197653778 @default.
- W4385514133 cites W3206483794 @default.
- W4385514133 cites W3207750149 @default.
- W4385514133 cites W3210468723 @default.
- W4385514133 cites W3210653355 @default.
- W4385514133 cites W3212147235 @default.
- W4385514133 cites W3217380207 @default.
- W4385514133 cites W4200014864 @default.
- W4385514133 cites W4200188493 @default.